Merck Q3 Keytruda Sales Reach $8.60 Billion
Story updates
10:30:55 AM UTC
SquawkNews
MERCK Q3 WORLDWIDE SALES $18.09 BLN VS IBES ESTIMATE $17.31 BLN
Related stories
Lilly Raises Sales Outlook by $5.5 Billion, Cuts EPS Forecast
Eli Lilly reported third-quarter non-GAAP EPS of $7.48 versus analysts’ consensus of $5.68 and revenue of $24.4 billion versus $22.58 billion. Revenue rose 39%, with volume up 53%
M impact | EARNINGS | Oct 29, 2026, 03:41 PM UTC
Hershey warns cost-of-living pressures may cool Halloween demand
Hershey's third-quarter net sales slightly exceeded LSEG expectations.
M impact | EARNINGS | Oct 29, 2026, 03:31 PM UTC
ServiceNow Shares Fall Nearly 15% After Earnings Shortfall
ServiceNow shares plunged nearly 15% Thursday morning after an earnings shortfall, despite revenue of $4.106 billion, up 20.5% year over year and slightly above a…
M impact | EARNINGS | Oct 29, 2026, 03:27 PM UTC
Basler shares jump after third annual forecast increase this year
Basler shares rose after the company raised its annual forecast for the third time this year.
M impact | EARNINGS | Oct 29, 2026, 03:23 PM UTC
Carvana Shares Jump 17.3% After Record Third-Quarter Results
Carvana reported record third-quarter 2026 financial results and guided full-year adjusted EBITDA toward the high end of its forecast range.
M impact | EARNINGS | Oct 29, 2026, 03:18 PM UTC
Carvana Rises After Third-Quarter Revenue Tops Expectations
M impact | EARNINGS | Oct 29, 2026, 03:18 PM UTC